ESR1 and carcinoma: Considering the genetic and epigenetic complexities of an advanced carcinoma, combined multifunctional agents/drugs such as ACAE (in this study), triterpenoids, rexinoids, selective estrogen-receptor modulators (SERMS) and deltanoids [32–34] could target multiple signaling pathways in the prevention and treatment of cancer.